Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for detecting drug resistance of antituberculosis drugs based on overlap-extension PCR

A detection method and overlapping extension technology, applied in the genetic field, can solve problems such as increased economic burden on patients, false false drug resistance results, inconsistent sequencing results, etc., and achieve good social benefits, reduce economic burden, and reduce detection costs.

Active Publication Date: 2019-08-13
重庆市公共卫生医疗救治中心
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] In summary, these genotypic drug resistance detection methods have the advantages of high efficiency and rapidity, and can quickly diagnose tuberculosis and some drug resistance, but because of the relatively high cost of detection
Expensive prices increase the financial burden on patients in poor areas
There are still a small number of cases where the test results are not consistent with the sequencing results. In the case of synonymous mutations in the probe binding sites in the coding regions of drug resistance-related genes, false false drug resistance results appear.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for detecting drug resistance of antituberculosis drugs based on overlap-extension PCR
  • Method for detecting drug resistance of antituberculosis drugs based on overlap-extension PCR
  • Method for detecting drug resistance of antituberculosis drugs based on overlap-extension PCR

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0049] The method for detecting drug resistance of anti-tuberculosis drugs based on overlap extension PCR is as follows:

[0050] 1. Overlap extension PCR amplifies fusion fragments (see principle figure 1 )

[0051] (1) DNA extraction:

[0052] Take the DNA extraction kit for Mycobacterium tuberculosis, operate according to the instructions, or use the boiling method to extract the DNA of the sample as a template; (normal saline is used as a negative control, because there is no natural rpoB-embB-katG-inhA fusion fragment, no Set up positive control)

[0053] (2) Construct a PCR reaction system:

[0054] 10×BUFFER 5.0μl,

[0055] dNTPs 1.0μl(2.5mM each),

[0056] Hot start Taq enzyme 0.2μl (5U / μl),

[0057] Primer mixture 5μl (rpobF and inhR concentration 10μM, the primers are mixed according to the above ratio),

[0058] Template DNA 5μl,

[0059] Add water to a total of 50μl.

[0060] 3) PCR reaction program:

[0061] Taking ABI7500 as an example, the first step: 95°C for 5 minutes; the se...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a method for detecting the drug resistance of antituberculosis drugs based on an overlap-extension PCR. By adopting an overlap-extension PCR method, four drug-resistance related segments of rpoB, embB and katG genes and an inhA promoter are connected and amplified into a fusion segment with the length of about 700 bp in a single tube, drug-resistance mutation information of the four segments is obtained just through a one-time sequencing reaction, and accordingly the condition of drug resistance of some kind of mycobacterium tuberculosis to three kinds of first-line antituberculosis drugs is known. If the method is applied and popularized clinically, the detection cost is greatly reduced, the economic burden of a patient is reduced, and the good social benefit is achieved. In short, by means of the method that the single-tube PCR amplification rpoB-embB-katG-inhA fusion segment is used for sequencing, so that the drug resistance condition of three kinds of first-line antituberculosis drugs is detected, the economic burden is reduced for detection of clinical drug resistance tuberculosis, the detection accuracy is improved, and the method is easy and convenient to implement, accurate and low in cost.

Description

Technical field [0001] The present invention belongs to the field of gene technology, and relates to a method for detecting the resistance of three anti-tuberculosis drugs at a time based on overlap extension PCR. Background technique [0002] Tuberculosis (TB) is a chronic infectious disease caused by Mycobacterium tuberculosis (Mtb). It is a major public health problem that seriously endangers human health. In recent years, the drug resistance of Mycobacterium tuberculosis has gradually deteriorated, and the epidemic situation of drug-resistant tuberculosis is very serious, so the importance of diagnosis of drug-resistant tuberculosis has become increasingly prominent. Although the culture-based method is still the gold standard for the diagnosis of drug-resistant tuberculosis, the traditional drug susceptibility test to detect Mtb drug resistance takes up to several weeks, which delays the treatment of patients and may lead to the emergence of new drug resistance, which is lab...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/689C12Q1/6869C12Q1/04C12N15/11C12R1/32
CPCC12Q1/689C12Q1/6869C12Q2600/156C12Q2600/106C12Q2531/113C12Q2533/101Y02A50/30
Inventor 李俊刚李同心罗明王静陈耀凯唐神结
Owner 重庆市公共卫生医疗救治中心
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products